STRATEGIES FOR REDUCING SIDE EFFECTS OF DRUGS IN ONCOGEMATOLOGICAL DISEASES

Аннотация

Oncogematological diseases, especially in children, can cause serious negative effects and long-term health problems.

Тип источника: Журналы
Годы охвата с 2021
inLibrary
Google Scholar
f
201-202
0

Скачивания

Данные скачивания пока недоступны.
Поделиться
Turdaliyeva , N., & Sultanova , G. (2025). STRATEGIES FOR REDUCING SIDE EFFECTS OF DRUGS IN ONCOGEMATOLOGICAL DISEASES. Евразийский журнал академических исследований, 5(10(MPHAPP), 201–202. извлечено от https://www.inlibrary.uz/index.php/ejar/article/view/138342
0
Цитаты
Crossref
Сrossref
Scopus
Scopus

Аннотация

Oncogematological diseases, especially in children, can cause serious negative effects and long-term health problems.


background image

201

Volume 5, Issue 10: Special Issue
(EJAR)

ISSN: 2181-2020

MPHAPP

THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE

MODERN PHARMACEUTICS: ACTUAL

PROBLEMS AND PROSPECTS

TASHKENT, OCTOBER 17, 2025

in-academy.uz

STRATEGIES FOR REDUCING SIDE EFFECTS OF DRUGS IN

ONCOGEMATOLOGICAL DISEASES

Turdaliyeva M.M.

Sultanova G.A.

Tashkent Pharmaceutical Institute, Tashkent city, Republic of Uzbekistan

e-mail: turdaliyevamaftuna08@mail.com

https://doi.org/10.5281/zenodo.17332757

Relevance:

oncogematological diseases, especially in children, can cause serious negative

effects and long-term health problems. The side effects of the drugs used to treat these conditions can
reduce the quality of life of patients, making the treatment process more difficult. Treatments such as
chemotherapy, immunotherapy, radiotherapy can cause significant damage to children's immune
system and overall health. Therefore, in oncogematological diseases, it is of urgent importance to
reduce the side effects of drugs, increase the effectiveness of treatment and improve the quality of
life of patients. Today, effective treatments are needed to reduce the number of patients dying from
children's oncogematological diseases, but it is always relevant to reduce side effects and create safer
and more effective therapy for patients. This research will help develop strategies aimed at
minimizing the negative effects of drugs.

Purpose of the study:

the study envisages the following main objectives: to develop strategies

for choosing rational drugs to reduce the side effects of basic treatments such as chemotherapy and
radiotherapy. Taking into account genetic and clinical characteristics when prescribing drugs through
an individual approach to children. To study the effectiveness of drug combinations to reduce side
effects of drugs.To develop new treatment protocols and ensure effective and safe treatment through
clinical use.

Methods and methods:

literature analysis: an analysis of existing scientific literature, clinical

research and practical experiments on reducing drug side effects in the treatment of
Oncogematological diseases. Statistical analysis: mathematical and statistical methods are used to
analyze research results and obtain statistically significant results.

Results:

the expected results of the study include: Reducing side effects: with the help of the

selection of rational drugs, their combination and genetic individual approaches, even fewer side
effects are observed in the treatment of oncogematological diseases in children. Improving the
effectiveness of treatment: by testing new combinations of drugs, as well as individually adjusting
the dosage and treatment courses, the effectiveness of the treatment of oncogematological diseases
increases. New protocols: new treatment protocols will be developed to reduce the side effects of
medications, ensuring safer and more effective treatment for children. Pharmacogenetic analysis: with
the help of pharmacogenetic analysis, results are obtained in the study of the individual effects of
drugs, as well as in the optimization of genetically based therapies.Improved quality of life: as a result
of reduced side effects and effective treatment, the overall quality of life in children is significantly
improved..

Conclusions

: developing effective strategies to reduce drug side effects in the treatment of

Oncogematological diseases, provides safe and effective treatment options for patients. The
approaches developed in this study increase treatment effectiveness by providing an individual
approach to drug selection, especially for children, optimizing treatment protocols, and applying
genetic analysis. The results of the study will help to create safer and more effective methods for


background image

202

Volume 5, Issue 10: Special Issue
(EJAR)

ISSN: 2181-2020

MPHAPP

THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE

MODERN PHARMACEUTICS: ACTUAL

PROBLEMS AND PROSPECTS

TASHKENT, OCTOBER 17, 2025

in-academy.uz

dealing with oncogematological diseases. These lead to a reduction in the side effects of drugs,
especially for children, and an improvement in the quality of life.